Federal Register: FDA Issues Notice of Guidance on Assessing Adhesion for Transdermal and Topical Delivery Systems in ANDAs
August 01, 2026
August 01, 2026
WASHINGTON, Aug. 1 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is announcing the availability of a final guidance for industry titled "Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs." This guidance provides recommendations for the design and conduct of studies evaluating the adhesion performa . . .
* * *
The Food and Drug Administration (FDA) is announcing the availability of a final guidance for industry titled "Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs." This guidance provides recommendations for the design and conduct of studies evaluating the adhesion performa . . .